US2009326225A1PendingUtilityA1
Novel Process for the Preparation of Hexacyclic Compounds
Assignee: CHUGAI PHARMACEUTICAL CO LTDPriority: Feb 21, 2003Filed: Aug 25, 2009Published: Dec 31, 2009
Est. expiryFeb 21, 2023(expired)· nominal 20-yr term from priority
A61P 35/00C07D 491/14
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to novel processes for the preparation of compounds of the formula [1], wherein R 1 , R 2 , R 3 and R 4 are as defined in the claims and description as well as pharmaceutically acceptable salts thereof. The compounds of the formula [1] are hexacyclic compounds having potent anti-tumor activity.
Claims
exact text as granted — not AI-modified1 . A compound of formula [2]:
or a salt thereof; wherein:
R 1 and R 2 are independently hydrogen, halogen, (C 1 -C 5 )-alkyl or (C 1 -C 5 )-alkoxy;
R 3 is hydrogen; or
(C 1 -C 5 )-alkyl optionally substituted with one to three moieties independently selected from the group consisting of (C 1 -C 5 )-alkoxy, hydroxy, halogen, amino, (C 3 -C 7 )-cycloalkyl, heterocyclic ring or and aryl in which the aryl ring is optionally substituted with one to three moieties independently selected from the group consisting of hydroxy, (C 1 -C 5 )-alkoxy, amino, mono-(C 1 -C 5 )-alkylamino and di-(C 1 -C 5 )-alkylamino;
R 4 is hydrogen; or
(C 1 -C 10 )-alkyl, optionally substituted with one to three moieties independently selected from the group consisting of (C 1 -C 5 )-alkoxy, hydroxy, halogen, amino, mono-(C 1 -C 5 )-alkylamino, di-(C 1 -C 5 )-alkylamino, (C 3 -C 7 )-cycloalkyl, a heterocyclic ring and aryl in which the aryl ring is optionally substituted with one to three moieties independently selected from the group consisting of hydroxy, alkoxy, halogen, amino, mono-(C 1 -C 5 )-alkylamino and di-(C 1 -C 5 )-alkylamino; and
R 5 is —OH or —O—(C 1 -C 5 )-alkyl.
2 . A compound according to claim 1 , which is a compound of formula [2A]:
or a salt thereof.
3 . A process of preparing a compound of claim 1 , or a salt thereof, comprising:
a) ozonolysis of a compound of formula [4]:
or a salt thereof, in order to obtain a compound of formula [5]:
or a salt thereof;
b) cyclizing the compound of formula [5] with an amine R 4 —NH 2 to obtain a compound of formula [6]:
or a salt thereof; and
c) hydrogenating the nitro group of the compound of formula [6], or a salt thereof, in order to obtain a compound of formula [2]:
or a salt thereof; wherein:
R 1 and R 2 are independently hydrogen, halogen, (C 1 -C 5 )-alkyl or (C 1 -C 5 )-alkoxy;
R 3 is hydrogen; or
(C 1 -C 5 )-alkyl optionally substituted with one to three moieties independently selected from the group consisting of (C 1 -C 5 )-alkoxy, hydroxy, halogen, amino, (C 3 -C 7 )-cycloalkyl, heterocyclic ring and aryl in which the aryl ring is optionally substituted with one to three moieties independently selected from the group consisting of hydroxy, (C 1 -C 5 )-alkoxy, amino, mono-(C 1 -C 5 )-alkylamino and di-(C 1 -C 5 )-alkylamino;
R 4 is hydrogen; or
(C 1 -C 10 )-alkyl, optionally substituted with one to three moieties independently selected from the group consisting of (C 1 -C 5 )-alkoxy, hydroxy, halogen, amino, mono-(C 1 -C 5 )-alkylamino, di-(C 1 -C 5 )-alkylamino, (C 3 -C 7 )-cycloalkyl, a heterocyclic ring and aryl in which the aryl ring is optionally substituted with one to three moieties independently selected from the group consisting of hydroxy, alkoxy, halogen, amino, mono-(C 1 -C 5 )-alkylamino and di-(C 1 -C 5 )-alkylamino; and
R 5 is —OH or —O—(C 1 -C 5 )-alkyl.
4 . A process of preparing a compound of claim 2 , or a salt thereof, wherein said process comprises:
a′) ozonolysis of a compound of formula [4A]:
or a salt thereof, in order to obtain a compound of formula [5A]:
or a salt thereof;
b′) cyclizing the compound of formula [5A], or a salt thereof, with n-pentylamine in order to obtain a compound of formula [6A]:
or a salt thereof; and
c′) hydrogenating the nitro group of the compound of formula [6A], or a salt thereof, in order to obtain a compound of formula [2A]:
or a salt thereof.
5 . A process of preparing a compound of claim 1 , or a salt thereof, comprising:
a) ozonolysis of a compound of formula [4]:
or a salt thereof, in order to obtain a compound of formula [5]:
or a salt thereof,
d) hydrogenating the nitro group of the compound of formula [5], or a salt thereof, in order to obtain a compound of formula [7]:
or a salt thereof,
e) cyclizing the compound of formula [7], or a salt thereof, with an amine R 4 —NH 2 in order to obtain a compound of formula [2]:
or a salt thereof; wherein:
R 1 and R 2 are independently hydrogen, halogen, (C 1 -C 5 )-alkyl or (C 1 -C 5 )-alkoxy;
R 3 is hydrogen; or
(C 1 -C 5 )-alkyl optionally substituted with one to three moieties independently selected from the group consisting of (C 1 -C 5 )-alkoxy, hydroxy, halogen, amino, (C 3 -C 7 )-cycloalkyl, heterocyclic ring and aryl in which the aryl ring is optionally substituted with one to three moieties independently selected from the group consisting of hydroxy, (C 1 -C 5 )-alkoxy, amino, mono-(C 1 -C 5 )-alkylamino and di-(C 1 -C 5 )-alkylamino;
R 4 is hydrogen; or
(C 1 -C 10 )-alkyl, optionally substituted with one to three moieties independently selected from the group consisting of (C 1 -C 5 )-alkoxy, hydroxy, halogen, amino, mono-(C 1 -C 5 )-alkylamino, di-(C 1 -C 5 )-alkylamino, (C 3 -C 7 )-cycloalkyl, a heterocyclic ring and aryl in which the aryl ring is optionally substituted with one to three moieties independently selected from the group consisting of hydroxy, alkoxy, halogen, amino, mono-(C 1 -C 5 )-alkylamino and di-(C 1 -C 5 )-alkylamino; and
R 5 is —OH or —O—(C 1 -C 5 )-alkyl.
6 . A process of preparing a compound of claim 2 , or salt thereof, wherein said process comprises:
a′) ozonolysis of a compound of formula [4A]:
or a salt thereof, in order to obtain a compound of the formula [5A]:
or a salt thereof;
d′) hydrogenating the nitro group of the compound of formula [5A], or a salt thereof, in order to obtain a compound of formula [7A]:
or a salt thereof, and
e′) cyclizing the compound of formula [7A], or a salt thereof, with n-pentylamine in order to obtain a compound of formula [2A], or a salt thereof.
7 . A compound according to claim 1 , or a salt thereof, wherein R 3 is hydrogen, methyl, ethyl, propyl, hydroxymethyl, aminomethyl, chloromethyl, or trifluoromethyl.
8 . A compound according to claim 1 , or a salt thereof, wherein R 4 is methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1,1-dimethylethyl, 2-methylpropyl, 2,2-dimethylpropyl, n-pentyl, 3-methylbutyl, 2-n-hexyl, 3,3-dimethylbutyl, n-heptyl, n-octyl, benzyl, phenethyl, 2-(dimethylamino)ethyl, 2-(4-morpholino)ethyl, 3-(dimethylamino)propyl, 2-(pyridin-2-yl)ethyl, 2-(pyridin-3-yl)ethyl, 2-(4-methoxyphenyl)ethyl, 2-(4-chlorophenyl)ethyl, 2-(4-fluorophenyl)ethyl, or 3-phenylpropyl.
9 . A compound according to claim 1 , or a salt thereof, wherein:
R 1 is hydrogen; and R 2 is hydrogen or (C 1 -C 3 )-alkyl; R 3 is hydrogen; or
(C 1 -C 5 )-alkyl optionally substituted with one to three moieties independently selected from the group consisting of (C 1 -C 5 )-alkoxy, hydroxy, halogen, amino,
(C 3 -C 7 )-cycloalkyl, a heterocyclic ring and aryl;
R 4 is hydrogen; or
(C 1 -C 8 )-alkyl which is optionally substituted with one to three moieties independently selected from the group consisting of (C 1 -C 3 )-alkoxy, hydroxy, halogen, amino, mono-(C 1 -C 3 )-alkylamino, di-(C 1 -C 3 )-alkylamino, (C 3 -C 7 )-cycloalkyl, a heterocyclic ring and aryl in which the aryl ring is optionally substituted with one to three moieties independently selected from the group consisting of hydroxy, alkoxy and halogen; and
R 5 is —OH or —O—(C 1 -C 5 )-alkyl.
10 . A compound according to claim 1 , or a salt thereof, wherein:
R 1 and R 2 are hydrogen; R 3 is hydrogen, methyl, ethyl, propyl, hydroxymethyl, aminomethyl, chloromethyl, or trifluoromethyl; and R 4 is methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1,1-dimethylethyl, 2-methylpropyl, 2,2-dimethylpropyl, n-pentyl, 3-methylbutyl, 2-n-hexyl, 3,3-dimethylbutyl, n-heptyl, n-octyl, benzyl, phenethyl, 2-(dimethylamino)ethyl, 2-(4-morpholino)ethyl, 3-(dimethylamino)propyl, 2-(pyridin-2-yl)ethyl, 2-(pyridin-3-yl)ethyl, 2-(4-methoxyphenyl)ethyl, 2-(4-chlorophenyl)ethyl, 2-(4-fluorophenyl)ethyl, or 3-phenylpropyl; and R 5 is —OH or —O—(C 1 -C 5 )-alkyl.Join the waitlist — get patent alerts
Track US2009326225A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.